|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Full Time MBA |
Admitted
|
Round 1 | 2025 | 615 GMAT Focus | 3 | Other | Italy |
12 Dec 2024 01:52 PM
|
|
| Full Time MBA |
Admitted, ($$)
|
Round 1 | 2025 | 685 GMAT Focus | 3.8 | 0 | Pharmaceuticals and Biotech | United States |
12 Dec 2024 12:20 PM
|
| Full Time MBA |
Admitted
|
Round 1 | 2025 | 690 GMAT Classic | 3.3 | 4 | Consulting | Mexico |
12 Dec 2024 11:44 AM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 3.6 | 10 | Pharmaceuticals and Biotech | United States |
12 Dec 2024 10:56 AM
|
|
| Full Time MBA |
Admitted
|
Round 2 | 2025 | 675 GMAT Focus | 3.2 | 5 | Technology | Canada |
12 Dec 2024 07:55 AM
|
| Full Time MBA |
Waitlisted without Interview
|
Round 1 | 2025 | 710 GMAT Classic | 4 | 4 | Real Estate | India |
09 Dec 2024 06:17 AM
|
| Full Time MBA |
Waitlisted without Interview
|
Round 1 | 2025 | 700 GMAT Classic | 3.7 | 5 | Finance: Venture Capital | Chile |
05 Dec 2024 04:56 PM
|
| Full Time MBA |
Waitlisted without Interview
|
Round 1 | 2025 | 715 GMAT Focus | 3.8 | 10 | Technology | United States |
05 Dec 2024 08:45 AM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 685 GMAT Focus | 3.8 | 6 | Other | Canada |
04 Dec 2024 11:32 AM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 655 GMAT Focus | 3 | Healthcare/Pharmaceuticals | Brazil |
28 Nov 2024 08:18 AM
|
|
| Full Time MBA |
Waitlisted without Interview
|
Round 1 | 2025 | 770 GMAT Classic | 8.1 | 5 | Finance | United States |
26 Nov 2024 05:43 PM
|
| MIT Sloan Fellows |
Interviewed
|
Round 1 | 2025 | 153 EA | 16 | Finance: Investment Banking | Poland |
22 Nov 2024 12:10 AM
|
|
| Full Time MBA |
Interviewed
|
Round 1 | 2025 | 330 GRE | 3.5 | 4 | Other | United States |
19 Nov 2024 01:22 PM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 695 GMAT Focus | 6.8 | 5 | Consulting | India |
01 Nov 2024 07:55 AM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 715 GMAT Focus | 7.2 | 4 | Consulting | India |
31 Oct 2024 05:27 AM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 735 GMAT Focus 655 GMAT Focus |
7.2 | 3 | Technology | India |
29 Oct 2024 10:21 PM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 645 GMAT Focus | 6.5 | 6 | Finance | France |
29 Oct 2024 12:38 PM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 705 GMAT Focus | 8.2 | 6 | Technology | India |
29 Oct 2024 07:11 AM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 314 GRE 322 GRE |
7.3 | 9 | Finance: Investment Management | India |
29 Oct 2024 05:23 AM
|
| Full Time MBA |
Waitlisted without Interview
|
Round 1 | 2025 | 715 GMAT Focus | 8.5 | 5 | Consulting | India |
29 Oct 2024 02:16 AM
|